Rapport Therapeutics Insider Sale: Is Bredt David’s Systematic Selling a Signal or Just Liquidity Management?
Insider selling at Rapport Therapeutics shows a disciplined, pre‑planned approach, not panic, and highlights the company’s Phase 3 pipeline potential.
3 minutes to read